政策筹备阶段同步创新监管服务，助乐城快速引进"零关税"进口药械 无缝衔接推动政策出台即见效 海南日报全媒体记者 李豌 中国患者再一次与全球同步享受到最新产品和技术。 日前，全球领先的人工听觉技术研发企业科利耳全球首发智能人工耳蜗植入系统Nexa，该系统同 步落地博鳌乐城国际医疗旅游先行区树兰(博鳌)医院，并完成全球上市后首批临床使用。当天，7名感 音神经性耳聋患者在该院接受首批Nexa智能人工耳蜗植入手术。 "这是我们医院通过'零关税'进口药械政策引进的首款医疗器械，第一批购买50套，涉及货值约 1500万元，减免税额超百万元。"树兰(博鳌)医院信息医工部主任龚仲之介绍，截至7月5日，已完成约 50台手术。 近半年来，乐城先行区多家医疗机构陆续引进了多款进口药品和医疗器械，正在惠及更多国内国际 患者。这得益于乐城先行区管理局等多部门推动"零关税"进口药品、医疗器械监管服务创新，率先探索 研发园区"政策准入—通关申报—临床使用"全链条区块链存证追溯系统，打造"单一窗口"与海关系统无 缝对接的医疗特区监管平台，推动"零关税"进口药品、医疗器械政策快速落地实施。 协同联动 探索创新监管服务机制 登录特许医疗综合追溯 ...

Key Takeaways WTS gains 26% over the past year, outpacing its industry, tech sector peers and the S&P 500. Strategic buys like I-CON and Josam fuel growth, adding millions to WTS' Americas segment sales. Nexa rollout and aggressive cost actions support margin expansion, despite softness in Europe sales.Watts Water Technologies, Inc. (WTS) continues to benefit from robust acquisitions, aggressive cost-reduction actions and a strong balance sheet.  The company’s shares have proved to be resilient amid a vol ...

Core Insights - Nexalin Technology, Inc. is hosting a webinar on June 3, 2025, to discuss its innovative approach to mental healthcare using its proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology [1][2] - The company is positioned in a $537 billion mental health market, with international regulatory approvals and U.S. expansion plans underway [2] - Nexalin's technology includes real-time AI-driven patient monitoring and aims to provide scalable, at-home treatment options [2] Company Overview - Nexalin designs and develops non-invasive neurostimulation products aimed at addressing the global mental health epidemic [4] - The company's devices are believed to penetrate deep brain structures associated with mental health disorders, enhancing patient response without adverse side effects [4] - The Nexalin Gen-2 15 milliamp neurostimulation device has received approval in China, Brazil, and Oman [4]

Core Insights - Nexxen has integrated generative AI into its Data Platform, enhancing its capabilities in automating and streamlining campaign strategy development [1][2] - The new nexAI Discovery assistant allows brands like LG Ad Solutions to translate audience behavior into actionable insights, facilitating faster campaign activation [1][4] Company Overview - Nexxen is a global advertising technology platform specializing in data and advanced TV, offering a flexible technology stack that includes a demand-side platform (DSP) and supply-side platform (SSP) [5] - The company aims to empower advertisers, agencies, publishers, and broadcasters by providing tools for discovery, planning, activation, monetization, measurement, and optimization [5] Key Features of nexAI - The integration of generative AI allows for the rapid generation of audience-specific market research and campaign strategies, reducing insight development time from days to minutes [6] - Nexxen Discovery analyzes user behavior across various platforms, providing a multidimensional view of audience preferences and trends [2][6] - The platform democratizes access to behavioral data and insights, enabling users to act without needing expert analysts [6] Client Benefits - Brands using nexAI can surface insights more quickly and with greater clarity, leading to smarter campaign decisions and improved outcomes [4] - The nexAI Discovery Assistant will be available for self-service access, with plans for broader availability and enhancements throughout the year [4]

报道称， 古瑞瓦特NEXA 2000系统通过GaN材料的应用，在逆变器性能上实现显著提升。该设备可承载20A的组串 电流，支持匹配650W高功率光伏组件，整套系统的太阳能输入容量达到2600W。 与传统硅基逆变器相比，氮化镓技术使得逆变器体积更小、效率更高，同时降低了系统发热量。该一体化系统内置2kWh 储能模块，并可通过扩展电池组将总容量提升至8kWh。目前该产品已在德国市场正式上市，售价约750欧元（约6000人民 币）。 随着全球能源转型加速，氮化镓在光储领域愈发展现出独特优势，众多GaN企业均积极通过旗下方案推动产业升级。以 英诺赛科 为例，他们已推出 基于氮化镓技术开发的2kW微型逆变器方案，采用Flyback+H桥逆变器架构，搭配 150V/650V GaN器件，可在屋顶光伏等场景中实现更高功率密度与效率。 终端应用方面，据《 2024-2025 氮化镓（GaN）产业调研白皮书 》阶段性调研统计， 目前已有昱能科技、移族、大 恒能源等 十余家 企 业已 实现GaN光储产品量产，覆盖从太阳能光伏到工业级储能全场景。 | 插播： | 英诺赛科、能华半导体、致能科技、京东方华灿光电、镓奥科 | | -- ...

Generated record Q1 Contribution ex-TAC and programmatic revenue, driven by 40% year-over-year CTV revenue growth, alongside a 95% year-over-year increase in Adjusted EBITDA Trading structure simplification has driven higher trading volume as well as increased analyst and investor interest Completed $50 million Ordinary Share repurchase program and launched a new and ongoing $50 million repurchase program in April 2025 Hosting investor day on May 22, 2025 NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Nexxen ...

Stevanato Group (STVN) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining the Stevanato Group First Quarter twenty twenty five Results Conference Call. As a reminder, all participants are in listen only mode. After the presentation, there will be an opportunity to ask questions. At this time, I would like to turn the conference over to Ms. Lisa Miles, Senior Vice President, Investor Relations. Please go ahead ...

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the closing of its previously announced underwritten public offering of 3,850,000 shares of its common stock at a public offering price of $1.30 per share. The gross proceeds from the offering to Nexalin were approximately $5.0 million, before deducting underwriting discounts and commissions and othe ...

Company Overview - Nexalin Technology, Inc. is a leader in Deep Intracranial Frequency Stimulation (DIFS™) technology aimed at addressing mental health issues through innovative neurostimulation products [5] - The company's products are designed to be non-invasive and are believed to provide relief for individuals suffering from mental health disorders [5] Public Offering Details - Nexalin announced a public offering of 3,850,000 shares of common stock priced at $1.30 per share, with expected gross proceeds of approximately $5.0 million [1] - The offering is set to close on or about May 6, 2025, subject to customary closing conditions [1] - An additional 577,500 shares may be purchased by underwriters within a 45-day option period at the public offering price [1] Use of Proceeds - The net proceeds from the offering will be utilized for working capital and general corporate purposes, including sales and marketing, product development, and capital expenditures [2] Regulatory Compliance - A shelf registration statement for the shares was filed with the SEC on April 23, 2025, and was declared effective on April 29, 2025 [3] - The offering is being conducted through a written prospectus and prospectus supplement available on the SEC's website [3]

FMC (FMC) Q1 2025 Earnings Call May 01, 2025 09:00 AM ET Speaker0 Ladies and gentlemen, this is the operator. Today's FMC Corporation conference call is scheduled to begin momentarily. If you should experience difficulties during today's call, please signal a conference specialist by pressing the star key followed by zero. Your lines will be placed Good morning, and welcome to the First Quarter twenty twenty five Earnings Call for the FMC Corporation. This event is being recorded. All participants are in a ...